| 前收市價 | 0.3366 |
| 開市 | 0.3343 |
| 買盤 | 0.3520 x 900 |
| 賣出價 | 0.3650 x 2900 |
| 今日波幅 | 0.3319 - 0.3789 |
| 52 週波幅 | 0.2640 - 2.5200 |
| 成交量 | |
| 平均成交量 | 60,237,388 |
| 市值 | 824.954M |
| Beta 值 (5 年，每月) | 1.14 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.4300 |
| 業績公佈日 | 2024年3月01日 - 2024年3月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 1.21 |
ZacksAfter Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)
Ginkgo Bioworks (DNA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
